| Author | Peirano, Gisele | |
| Author | Souza, Flávia dos Santos | |
| Author | Rodrigues, Dália dos Prazeres | |
| Access date | 2019-10-31T17:57:56Z | |
| Available date | 2019-10-31T17:57:56Z | |
| Document date | 2006 | |
| Citation | PEIRANO, Gisele; SOUZA, Flávia dos Santos; RODRIGUES, Dalia dos Prazeres. Frequency of serovars and antimicrobial resistance in Shigella spp. from Brazil. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 101, n. 3, p. 245-250, May 2006. | pt_BR |
| ISSN | 0074-0276 | pt_BR |
| URI | https://www.arca.fiocruz.br/handle/icict/36787 | |
| Language | eng | pt_BR |
| Publisher | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz | pt_BR |
| Rights | open access | |
| Subject in Portuguese | Vigilância da resistência antimicrobiana | pt_BR |
| Subject in Portuguese | Serovares | pt_BR |
| Subject in Portuguese | Shigella | pt_BR |
| Subject in Portuguese | Brasil | pt_BR |
| Title | Frequency of serovars and antimicrobial resistance in Shigella spp. from Brazil | pt_BR |
| Type | Article | |
| DOI | 10.1590/S0074-02762006000300003 | |
| Abstract | A total of 296 Shigella spp. were received from State Public Health Laboratories, during the period from 1999 to 2004, by National Reference Laboratory for Cholera and Enteric Diseases (NRLCED) - IOC/Fiocruz, Rio de Janeiro, Brazil. The frequency of Shigella spp. was: S. flexneri (52.7%), S. sonnei (44.2%), S. boydii (2.3%), and S. dysenteriae (0.6%). The most frequent S. flexneri serovars were 2a and 1b. The highest incidence rates of Shigella isolation were observed in the Southeast (39%) and Northeast (34%) regions and the lowest rate in the South (3%) of Brazil. Strains were further analyzed for antimicrobial susceptibility by disk diffusion method as part of a surveillance program on antimicrobial resistance. The highest rates of antimicrobial resistance were to trimethoprimsulfamethozaxole (90%), tetracycline (88%), ampicillin (56%), and chloramphenicol (35%). The patterns of antimicrobial resistance among Shigella isolates pose a major difficulty in the determination of an appropriate drug for shigellosis treatment. Continuous monitoring of antimicrobial susceptibilities of Shigella spp. through a surveillance system is thus essential for effective therapy and control measures against shigellosis. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Referência Nacional de Cólera e outras Enteroinfecções Bacterianas. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Referência Nacional de Cólera e outras Enteroinfecções Bacterianas. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Affilliation | Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Referência Nacional de Cólera e outras Enteroinfecções Bacterianas. Rio de Janeiro, RJ, Brasil. | pt_BR |
| Subject | Shigella | pt_BR |
| Subject | Serovars | pt_BR |
| Subject | Antimicrobial resistance surveillance | pt_BR |
| Subject | Brazil | pt_BR |
| e-ISSN | 1678-8060 | |
